Effect of supplementation in treatment of patients with diabetic nephropathy
Phase 3
- Conditions
- Diabetic nephropathy.Glomerular disorders in diabetes mellitus (E10-E14 with common fourth character .2+)N08.3
- Registration Number
- IRCT2017061134458N1
- Lead Sponsor
- Vice chancellor for research, Kashan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Patients with diabetic nephropathy aged 45 to 85 years
Exclusion Criteria
History of active infection within 3 months
Intake of probioticand/or synbiotic supplements within 3 months
History of hospitaladmission within 3 months
Malignancy and/or liver cirrhosis
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Insulin resistance. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Calculation using HOMA formula.
- Secondary Outcome Measures
Name Time Method